Filed Pursuant to Rule 424(b)(3)
Registration No. 333-268335
Prospectus Supplement No. 27
to Prospectus dated February 3, 2023
CHILEAN COBALT CORP.
39,000,000 Shares of Common Stock
$1.33 per Share
This prospectus supplement
No. 27 amends and supplements the prospectus dated February 3, 2023, which forms a part of our Registration Statement on Form S-1 (Registration
Statement No. 333-268335) (the “Registration Statement”) and prospectus supplement No. 1 filed on March 24, 2023, prospectus
supplement No. 2 filed on May 8, 2023, prospectus supplement No. 3 filed on May 15, 2023, prospectus supplement No. 4 filed on July 6,
2023, prospectus supplement No. 5 filed on July 12, 2023, prospectus supplement No. 6 filed on August 14, 2023, prospectus supplement
No. 7 filed on September 27, 2023, prospectus supplement No. 8 filed on November 9, 2023, prospectus supplement No. 9 filed on February
7, 2024, prospectus supplement No. 10 filed on April 1, 2024, prospectus supplement No. 11 filed on May 8, 2024, prospectus supplement
No. 12 filed on May 20, 2024, prospectus supplement No. 13 filed on June 14, 2024, prospectus supplement No. 14 filed on August 19, 2024,
prospectus supplement No. 15 filed on November 14, 2024, prospectus supplement No. 16 filed on January 3, 2025, prospectus supplement
No. 17 filed on February 27, 2025, prospectus supplement No. 18 filed on April 2, 2025, prospectus supplement No. 19 filed on May 15,
2025, prospectus supplement No. 20 filed on July 24, 2025, prospectus supplement No. 21 filed on July 29, 2025, prospectus supplement
No. 22 filed on August 14, 2025, prospectus supplement No. 23 filed on September 3, 2025, prospectus supplement No. 24 filed on September
15, 2025, prospectus supplement No. 25 filed on November 17, 2025 and prospectus supplement No. 26 filed on December 2, 2025 (collectively,
the “Supplements”) relating to the resale of up to 39,000,000 shares of common stock of Chilean Cobalt Corp. (the “Company,”
“C3,” “we,” “our” and “us”) by the selling stockholders named in the prospectus. The foregoing
prospectus, the Supplements and this prospectus supplement No. 27 are collectively referred to as the “prospectus.” Please
keep this prospectus supplement with your prospectus for future reference.
This prospectus supplement
incorporates into the prospectus the attached Current Report on Form 8-K, filed with the Securities and Exchange Commission (“SEC”)
on January 5, 2026.
This prospectus supplement
is not complete without the prospectus, including any supplements and amendments thereto. This prospectus supplement should be read in
conjunction with the prospectus which is to be delivered with this prospectus supplement. This prospectus supplement is qualified by reference
to the prospectus, except to the extent that the information in this prospectus supplement updates or supersedes the information contained
in the prospectus, including any supplements and amendments thereto.
Investing in our common
stock should be considered speculative and involves a high degree of risk, including the risk of losing your entire investment. See “Risk
Factors” section of the prospectus to read about the risks you should consider before buying shares of our common stock.
Neither the SEC nor any
state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.
Capitalized terms contained
in this prospectus supplement have the same meanings as in the prospectus unless otherwise stated herein.
The date of this prospectus supplement is January
5, 2026
Index of SEC Filings
The following report listed below is filed as a part of this prospectus
supplement No. 27.
| Appendix No. |
|
Description |
| |
|
|
| Appendix 1 |
|
Current Report on Form 8-K, filed with the Securities and Exchange Commission on January 5, 2026. |
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
December 31, 2025
CHILEAN COBALT CORP.
(Exact name of registrant as specified in its charter)
| Nevada |
|
333-268335 |
|
82-3590294 |
|
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification Number) |
1199 Lancaster Ave, Suite 107
Berwyn, Pennsylvania 19312
(Address of principal executive offices)
(484) 580-8697
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name
of each exchange on which registered |
| None. |
|
|
|
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item
3.03 |
Material Modification to Rights of Security Holders. |
On December 31, 2025, based
on the auto-conversion provisions of the Certificate of Amendment to Certificate of Designations of Preferences and Rights of Series B
Convertible Preferred Stock (the “Amended Series B Certificate”, as previously referenced by Exhibit 3.2 of the Form 8-K filed
on January 3, 2025 and again referenced herein), that were effective on December 31, 2025, all 2,407,785 issued and outstanding shares
of Series B Convertible Stock were converted to the Company’s common stock, increasing the total of the Company’s common stock
issued and outstanding to 56,409,930 shares and decreasing the Series B Convertible Stock issued and outstanding to 0 shares.
As a result of the conversion,
holders of the preferred stock ceased to have any rights, preferences, or privileges associated with the preferred stock, including anti-dilution
rights, and exchange preferences to issuances that are senior in debt structure or with more favorable conversion terms, and thereafter
hold only the rights of holders of the Company’s common stock.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
CHILEAN COBALT CORP |
| |
|
| Dated: January 5, 2026 |
By: |
/s/ Duncan T. Blount |
| |
Name: |
Duncan T. Blount |
| |
Title: |
Chief Executive Officer |